Lilly(Eli) & Company
NYSE: LLY
$759.36
-$5.35 (-0.7%)
Real Time Data Delayed 15 Min.
LLY Articles
Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm thinks these stocks could go on the offensive for the rest of the year.
Published:
These are five of the best stocks in a sector that has been humming along in what has been a turbulent year. They are all included on the Goldman Sachs Conviction List too.
Published:
Wednesday's top analyst upgrades and downgrades included Alphabet, Advanced Micro Devices, Corning, FireEye, Inovia Pharmaceuticals, Lululemon Athletica, Nike, Roku, Starbucks, Tyson Foods and...
Published:
The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Tuesday's top analyst upgrades and downgrades included American Airlines, Chewy, Chipotle Mexican Grill, CommScope, Eli Lilly, IBM, Lyft, Oneok, Stitch Fix, Valero Energy and Williams Companies.
Published:
24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports due this week, including Amazon, Tesla, Netflix and Starbucks.
Published:
The March 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
These five top growth stocks could follow up on their first-quarter success with another victory for shareholders in the second quarter. They make sense for more aggressive growth accounts looking...
Published:
Some investors are looking for conservative growth ideas, and big pharma may be the ticket. These four top stocks have been hit hard, and the companies have paid dependable dividends for years.
Published:
The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical stocks decreased.
Published:
The February 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
These five companies basically do all their business in the United States. They provide products or services that will be needed almost regardless of the severity or length of the coronavirus...
Published:
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
24/7 Wall St. screened the Merrill Lynch health care research database looking for large pharmaceutical leaders that also pay solid and dependable dividends. These five make sense for growth and...
Published:
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published: